Modeling of .beta.-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists

Journal of Medicinal Chemistry
1988.0

Abstract

The molecular electrostatic potential (MEP) of 32 beta-adrenoceptor ligands, mainly antagonists, was calculated by the STO-3G ab initio quantum mechanical method. The MEP of phenylethanolamines (PEAs) features a negative minimum in the meta region (designated M1) which is topographically equivalent to a minimum (designated M2) found in the vicinity of the aromatic ring in all (aryloxy)propanolamines (AOPAs). In these compounds, a second negative zone located beyond the meta position and designated M3 is found in all beta 1-selective antagonists and in some nonselective and beta 2-selective antagonists. The beta 1-selective antagonists feature in the para position an additional zone which is positive (P4) in the full antagonists and negative (M4) in the antagonists displaying intrinsic sympathomimetic activity (ISA). The MEP-based pharmacophoric models of PEAs, AOPAs, and oxime ethers show common elements and lead to a proposed general model for beta-adrenoceptor ligands.

Knowledge Graph

Similar Paper

Modeling of .beta.-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists
Journal of Medicinal Chemistry 1988.0
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties
Journal of Medicinal Chemistry 1990.0
Quantitative evaluation of the .beta.2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines
Journal of Medicinal Chemistry 1985.0
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain
Journal of Medicinal Chemistry 1982.0
Computer-aided mapping of the .beta.-adrenoceptor I: Explanation for effect of para substitution on blocking activity at the .beta.-1-adrenoceptor
Journal of Medicinal Chemistry 1992.0
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of .alpha.- and .beta.-adrenergic receptors
Journal of Medicinal Chemistry 1992.0
Quantitative evaluation of the .beta.2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines
Journal of Medicinal Chemistry 1986.0
2-Methoxyphenylethanolamines, potential .beta.-adrenergic blocking agents
Journal of Medicinal Chemistry 1978.0
Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β2-adrenergic receptor
Bioorganic & Medicinal Chemistry 2014.0
Conformational effects on the activity of drugs. 11. Stereostructural models for the direct activation of the .alpha.- and .beta.-adrenergic receptor
Journal of Medicinal Chemistry 1986.0